Tenascin-C inhibits beta1 integrin-dependent cell adhesion and neurite outgrowth on fibronectin by a disialoganglioside-mediated signaling mechanism

Glycobiology. 1999 Feb;9(2):101-14. doi: 10.1093/glycob/9.2.101.

Abstract

We have previously shown that the extracellular matrix molecule tenascin-C inhibits fibronectin-mediated cell adhesion and neurite outgrowth by an interaction with a cellular RGD-independent receptor which interferes with the adhesion and neurite outgrowth promoting activities of the fibronectin receptor(s). Here we demonstrate that the inhibitory effect of tenascin-C on beta1integrin-dependent cell adhesion and neurite outgrowth is mediated by the interaction of the protein with membrane-associated disialogangliosides, which interferes with protein kinase C-related signaling pathways. First, in substratum mixtures with fibronectin, an RGD sequence-containing fragment of the molecule or synthetic peptide, tenascin-C inhibited cell adhesion and spreading by a disialoganglioside-dependent, sialidase-sensitive mechanism leading to an inhibition of protein kinase C. Second, the interaction of intact or trypsinized, i.e., cell surface glycoprotein-free, cells with immobilized tenascin-C was strongly inhibited by gangliosides or antibodies to gangliosides and tenascin-C. Third, preincubation of immobilized tenascin-C with soluble disialogangliosides resulted in a delayed cell detachment as a function of time. Similar to tenascin-C, immobilized antibody to GD2 (3F8) or sphingosine, a protein kinase C inhibitor, strongly inhibited RGD-dependent cell spreading. Finally, the degree of tenascin-C-induced inhibition of cell adhesion was proportional to the degree of disialoganglioside levels of expression by different cells suggesting the relevance of such mechanism in modulating integrin-mediated cell-matrix interactions during pattern formation or tumor progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion / drug effects*
  • Cells, Cultured
  • Drug Interactions
  • Fibronectins / pharmacology*
  • G(M1) Ganglioside / pharmacology
  • G(M2) Ganglioside / pharmacology
  • Gangliosides / metabolism*
  • Gangliosides / pharmacology
  • Glycosphingolipids / pharmacology
  • Humans
  • Integrin beta1 / metabolism*
  • Mice
  • Neurites / drug effects*
  • Oligopeptides
  • Receptors, Cell Surface / metabolism*
  • Signal Transduction
  • Tenascin / pharmacology*

Substances

  • Fibronectins
  • Gangliosides
  • Glycosphingolipids
  • Integrin beta1
  • Oligopeptides
  • Receptors, Cell Surface
  • Tenascin
  • sialogangliosides
  • G(M2) Ganglioside
  • G(M1) Ganglioside
  • trisialoganglioside GT1
  • arginyl-glycyl-aspartic acid